AU2000255261A1 - Means for maintenance and/or correction of glucose concentration in blood - Google Patents

Means for maintenance and/or correction of glucose concentration in blood

Info

Publication number
AU2000255261A1
AU2000255261A1 AU2000255261A AU5526100A AU2000255261A1 AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1 AU 2000255261 A AU2000255261 A AU 2000255261A AU 5526100 A AU5526100 A AU 5526100A AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1
Authority
AU
Australia
Prior art keywords
blood
correction
maintenance
glucose concentration
polymeric matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000255261A
Other languages
English (en)
Inventor
Iouri Gennadievich Bobkov
Anatoliy Borisovich Davydov
Iouri Tikhonovich Kalinin
Gennadiy Ljvovich Khromov
Boris Ivanovich Leonov
Tatjana Igorevna Solodkaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ctp Cable Technology Procurement AG
Original Assignee
C T P CABLE TECHNOLOGY PROCURE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C T P CABLE TECHNOLOGY PROCURE filed Critical C T P CABLE TECHNOLOGY PROCURE
Publication of AU2000255261A1 publication Critical patent/AU2000255261A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AU2000255261A 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood Abandoned AU2000255261A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2000/004826 WO2001091784A1 (fr) 2000-05-26 2000-05-26 Systeme de maintien et/ou de correction de la glycemie

Publications (1)

Publication Number Publication Date
AU2000255261A1 true AU2000255261A1 (en) 2001-12-11

Family

ID=8163961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000255261A Abandoned AU2000255261A1 (en) 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood

Country Status (6)

Country Link
US (1) US7259139B1 (fr)
EP (1) EP1289542B1 (fr)
AT (1) ATE401095T1 (fr)
AU (1) AU2000255261A1 (fr)
DE (1) DE60039540D1 (fr)
WO (1) WO2001091784A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687608B2 (en) 2005-10-19 2010-03-30 Smartcells, Inc. Methods for reducing the mitogenicity of lectin compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
EP0842209B1 (fr) * 1995-07-28 2006-10-11 Genzyme Corporation Hydrogels multiblocs biodegradables destines a etre utilises comme agents de liberation regulee pour l'administration de medicaments et le traitement de tissus
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning

Also Published As

Publication number Publication date
EP1289542B1 (fr) 2008-07-16
EP1289542A1 (fr) 2003-03-12
DE60039540D1 (de) 2008-08-28
ATE401095T1 (de) 2008-08-15
US7259139B1 (en) 2007-08-21
WO2001091784A1 (fr) 2001-12-06

Similar Documents

Publication Publication Date Title
WO2006052285A3 (fr) Nanoparticules et nanogels polymeres pour l'extraction et la liberation de composes
WO2005044224A3 (fr) Systeme d'administration de medicament, faisant appel a des nanocoques polymeres
SI0973819T1 (sl) Neantigenski razvejeni polimerni konjugati
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
GB9902652D0 (en) Process
DK1028753T3 (da) Indgivelse af poly(ethylenglycol)-konjugerede molekyler fra nedbrydellige hydrogeler
AU6559800A (en) Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
AU7576896A (en) Lipopolyamines as transfection agents and their pharmaceutical applications
WO2002039948A3 (fr) Gels de laminine et d'acide hyaluronique reticule et leur utilisation dans la culture cellulaire et les implants medicaux
ATE267613T1 (de) Arzneimittel und deren verwendung
WO2002064184A3 (fr) Procede de preparation d'un implant chirurgical
DE60028152D1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher Komplex von Orthokieselsäure und Prozess zur dessen Herstellung
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU1263400A (en) Stable aqueous insulin preparations without phenol and cresol
BRPI0414979A (pt) preparação sólida
WO2003008430A3 (fr) Derives de porphyrine utilises en therapie photodynamique
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
DE60018564D1 (de) Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung
Saad et al. Biodegradable polymeric materials
AU2668400A (en) Human antibiotic proteins
WO1999061014A3 (fr) Compositions et methodes utilisant de la r(-) fluoxetine et d'autres ingredients actifs
AU3163100A (en) Benzofuran-2-one
AU2000255261A1 (en) Means for maintenance and/or correction of glucose concentration in blood
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
MX9805939A (es) Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.